Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01816698
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Zhiming Zhu
- Registry
-
NCT01816698
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01816698. Randomized; quadruple masking; primary purpose prevention. Start 2012-12 (registry gives no type); primary completion 2015-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive
- Acronym
- ESTAB
- Condition
- Prehypertension
- Intervention (Drug)
- Taurine granule
- Intervention (Drug)
- Placebo
- Lead sponsor
- Zhiming Zhu
Record details
- Record id
cardio:ct-nct01816698- Content hash
9d8c612e42ec4e45660546bc06a9e6d48f3e15d2371139982b91098cf3fe2e02